Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies 2020-10-28 21:00
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition 2020-10-28 07:00
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history 2020-10-27 20:00
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China 2020-10-27 08:13
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) 2020-10-27 07:23
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis 2020-10-26 19:40
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus 2020-10-26 16:35
RhoVac Participates in BIO Europe Digital 2020-10-26 16:26
PharmAbcine to participate at BIO-Europe 2020 2020-10-23 20:00
TUV Rheinland Announces the Opening of its NABL Accredited Biomaterial and EMC Testing Laboratories 2020-10-23 09:15
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities 2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting 2020-10-22 19:30
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 2020-10-22 14:00
Samsung Biologics' strategic business operations continue to support strong third quarter earnings 2020-10-21 19:00
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China 2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification 2020-10-21 10:00
1 234 235 236 237 238 413